Cellular Plasticity Cascades in the Pathophysiology and Treatment of Bipolar Disorder

被引:0
作者
Robert J Schloesser
Jian Huang
Peter S Klein
Husseini K Manji
机构
[1] Laboratory of Molecular Pathophysiology,Department of Medicine (Hematology
[2] Mood and Anxiety Disorders Program,Oncology)
[3] National Institute of Mental Health,undefined
[4] NIH,undefined
[5] University of Pennsylvania School of Medicine,undefined
来源
Neuropsychopharmacology | 2008年 / 33卷
关键词
bipolar disorder; neuroplasticity; intracellular signaling cascades; lithium; valproic acid; mood stabilizer;
D O I
暂无
中图分类号
学科分类号
摘要
Bipolar disorder (BPD) is characterized by recurrent episodes of disturbed affect including mania and depression as well as changes in psychovegetative function, cognitive performance, and general health. A growing body of data suggests that BPD arises from abnormalities in synaptic and neuronal plasticity cascades, leading to aberrant information processing in critical synapses and circuits. Thus, these illnesses can best be conceptualized as genetically influenced disorders of synapses and circuits rather than simply as deficits or excesses in individual neurotransmitters. In addition, commonly used mood-stabilizing drugs that are effective in treating BPD have been shown to target intracellular signaling pathways that control synaptic plasticity and cellular resilience. In this article we draw on clinical, preclinical, neuroimaging, and post-mortem data to discuss the neurobiology of BPD within a conceptual framework while highlighting the role of neuroplasticity in the pathophysiology and treatment of this disorder.
引用
收藏
页码:110 / 133
页数:23
相关论文
共 993 条
[1]  
Acharya JK(1998)Synaptic defects and compensatory regulation of inositol metabolism in inositol polyphosphate 1-phosphatase mutants Neuron 20 1219-1229
[2]  
Labarca P(1998)The Bcl-2 protein family: arbiters of cell survival Science 281 1322-1326
[3]  
Delgado R(1995)T2 hyperintensities in bipolar disorder: magnetic resonance imaging comparison and literature meta-analysis Am J Psychiatry 152 1139-1144
[4]  
Jalink K(2007)Does long-term medication with lithium prevent or attenuate dementia in bipolar and depressed patients? Int J Psychiatry Clin Pract 11 2-8
[5]  
Zuker CS(2007)Glycogen synthase kinase-3 is required for optimal Mol Microbiol 63 1248-1258
[6]  
Adams JM(1967) synthesis of inositol Arch Gen Psychiatry 16 162-172
[7]  
Cory S(2005)Lithium as a prophylactic agents. Its effect against recurrent depressions and manic-depressive psychosis Mol Neurobiol 32 173-202
[8]  
Altshuler LL(1999)Mood stabilizers target cellular plasticity and resilience cascades: implications for the development of novel therapeutics J Neuropsychiatry Clin Neurosci 11 71-78
[9]  
Curran JG(1999)Reduced volume of limbic system-affiliated basal ganglia in mood disorders: preliminary data from a postmortem study J Affect Disord 54 217-224
[10]  
Hauser P(2008)Unipolar-bipolar dichotomy of mood disorders is supported by noradrenergic brainstem system morphology Neuropsychopharmacology Rev 33 84-87